Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CutA divalent cation tolerance homolog-like, pseudogene (CUTALP)
- Target
- CUTALP
- Molecular classification
- Long non-coding RNA (lncRNA), Pseudogene
01
Overview
CUTALP stands for "cutA divalent cation tolerance homolog-like, pseudogene." It is annotated as a long non-coding RNA (lncRNA) pseudogene located on chromosome 9q33.2 in humans. As a pseudogene, it does not encode a functional protein product and is not a therapeutic target, receptor, enzyme, or transporter. Although some lncRNAs may have regulatory roles, no specific functional or disease associations have been reported for this pseudogene. Its annotation can be a source of confusion because of its "target-like" gene symbol, but it is not a bona fide drug target or molecular receptor.
- Other names
- PSMD5 antisense RNA 1 (head to head)
02
Mechanism of action
None (no drugs or therapeutic mechanisms established)
03
Biological functions
Other (no well-defined biological function; as a pseudogene, it is generally considered non-coding and not directly functional, though like some lncRNAs it may have regulatory roles which are not clearly established for CUTALP in the literature)
04
Disease associations
Other (no clear role established in disease; not implicated in cancer, inflammation, or other diseases as a functional gene)
Beyond the preview
Go deeper on CutA divalent cation tolerance homolog-like, pseudogene (CUTALP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CutA divalent cation tolerance homolog-like, pseudogene (CUTALP).